Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Adma Biologics, Inc.

Close the divestiture of three plasma centers

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
25 Feb 2026
Due
31 Mar 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“the Company remains on track to close the transaction in the first quarter of 2026”

What we found

Evidence strength A What the grades mean

The company successfully completed the divestiture of three plasma collection centers during the first quarter of 2026, meeting its stated commitment.

  • A
    Adma Biologics, Inc. 10-Q filed 2026-05-06 Regulatory filing · published 6 May 2026 · retrieved 2 Oct 2026 · kept permanently by the SEC · fingerprint 723a7f31367a
    “The sale of these plasma centers was completed during the first quarter of 2026.” ✓ confirmed on the page

Market reaction: the shares moved -22.2% against the S&P 500 over the three sessions around the disclosure (5 May 2026 to 8 May 2026). What this measures

Checked 2 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Acquisition close
Indicative materiality
High rules
Action
Close
Deliverable
divestiture of three plasma centers
Language
Firm (“will”, “on track to”)
In the company’s control
High
Specificity
High
Depends on
Counterparty

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Adma Biologics, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2026-ADMA-003442 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.